A detailed history of Capital Wealth Planning, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Capital Wealth Planning, LLC holds 21,892 shares of NVO stock, worth $2.25 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
21,892
Previous 23,806 8.04%
Holding current value
$2.25 Million
Previous $3.4 Million 23.31%
% of portfolio
0.02%
Previous 0.04%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$119.07 - $145.42 $227,899 - $278,333
-1,914 Reduced 8.04%
21,892 $2.61 Million
Q2 2024

Aug 09, 2024

BUY
$122.71 - $146.91 $1.93 Million - $2.31 Million
15,731 Added 194.81%
23,806 $3.4 Million
Q1 2024

May 07, 2024

BUY
$102.11 - $135.92 $52,178 - $69,455
511 Added 6.76%
8,075 $1.04 Million
Q4 2023

Feb 08, 2024

BUY
$87.78 - $105.45 $663,967 - $797,623
7,564 New
7,564 $782,000
Q1 2023

May 04, 2023

BUY
$132.34 - $159.14 $532,800 - $640,697
4,026 New
4,026 $640,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $232B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Capital Wealth Planning, LLC Portfolio

Follow Capital Wealth Planning, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Wealth Planning, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Wealth Planning, LLC with notifications on news.